4.7 Article

Structural Characterization of a Gold/Serum Albumin Complex

期刊

INORGANIC CHEMISTRY
卷 58, 期 16, 页码 10616-10619

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.inorgchem.9b01900

关键词

-

资金

  1. Beneficentia Stiftung [19650]
  2. Ente Cassa Rismarmio Firenze [19650]
  3. Associazione Italiana per la Ricerca sul Cancro (AIRC) [19650]
  4. AIRC-Fondazione Italiana per la Ricerca sul Cancro (FIRC) [22587]
  5. AIRC [22294]
  6. Fondazione CR Firenze [22294]

向作者/读者索取更多资源

The medicinal gold(III) dithiocarbamato complex AuL12 forms a stable adduct with bovine serum albumin. The crystal structure reveals that a single gold(I) center is bound to Cys34, with the dithiocarbamato ligand being released. To the best of our knowledge, this is the first structure for a gold adduct of serum albumin.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Inorganic & Nuclear

Is the Next Cisplatin Already in Our Laboratory?

Damiano Cirri, Lorenzo Chiaverini, Alessandro Pratesi, Tiziano Marzo

Summary: Since the accidental discovery of cisplatin, numerous inorganic molecules have been synthesized in search of new anticancer drugs with powerful activity and safety. Unfortunately, the ideal combination has yet to be achieved. Apart from cisplatin, only two platinum-based drugs, carboplatin and oxaliplatin, have been approved globally, both of which are cisplatin-like molecules. Therefore, we aim to summarize the reasons for the lack of newly approved molecules and rationalize the critical steps in the discovery and approval process of improved anticancer metallodrugs, stimulating an open and critical scientific debate.

COMMENTS ON INORGANIC CHEMISTRY (2023)

Article Chemistry, Inorganic & Nuclear

A biophysical study of the interactions of palladium(ii), platinum(ii) and gold(iii) complexes of aminopyridyl-2,2′-bipyridine ligands with RNAs and other nucleic acid structures

Francesca Binacchi, Cassandra Elia, Damiano Cirri, Corjan van de Griend, Xue-Quan Zhou, Luigi Messori, Sylvestre Bonnet, Alessandro Pratesi, Tarita Biver

Summary: Metal compounds are attractive ligands for various nucleic acids. Five metal complexes with aminopyridyl-2,2'-bipyridine tetradentate ligands and quasi-planar geometry were studied for their binding to different nucleic acid molecules. The binding preferences and structural features of the metal complexes were analyzed using spectroscopy and melting methods.

DALTON TRANSACTIONS (2023)

Article Biochemistry & Molecular Biology

Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex

Giovanni Canil, Juan Gurruchaga-Pereda, Simona Braccini, Lorella Marchetti, Tiziana Funaioli, Fabio Marchetti, Alessandro Pratesi, Luca Salassa, Chiara Gabbiani

Summary: Photoactivatable Pt(IV) prodrugs have great potential as metal-based drugs due to their chemical inertness in oxidized form and selective targeting compared to Pt(II) compounds. A new Pt(IV) complex, soluble in water and unreactive until reduction, was synthesized. The complex exhibited rapid and efficient photoreduction with visible light, facilitated by a catalytic system based on flavin and NADH. The reactivity of the prodrug against biological targets was only observed after photoreduction to its Pt(II) analogue.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments

Ester Giorgi, Francesca Binacchi, Carlo Marotta, Damiano Cirri, Chiara Gabbiani, Alessandro Pratesi

Summary: Despite progress, cancer still poses challenges due to side effects, resistance, and poor selectivity of current metal-based therapies. New strategies reviewed include using heterobimetallic complexes containing different metal centers and conjugating metal complexes to target cancer cells. Examples of targeting organelles and the entire cancer cell were highlighted.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues

Damiano Cirri, Andrea Geri, Lara Massai, Michele Mannelli, Tania Gamberi, Francesca Magherini, Matteo Becatti, Chiara Gabbiani, Alessandro Pratesi, Luigi Messori

Summary: A panel of four novel gold(I) complexes, inspired by the clinically established gold drug auranofin, were prepared and characterized. The differences in their interactions with model proteins were analyzed, and their cytotoxic effects on ovarian cancer cells were quantitated. These novel gold complexes showed potential as effective anticancer agents.

MOLECULES (2023)

Article Chemistry, Inorganic & Nuclear

An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies

Carlo Marotta, Ester Giorgi, Francesca Binacchi, Damiano Cirri, Chiara Gabbiani, Alessandro Pratesi

Summary: The discovery of cisplatin's antineoplastic properties in 1965 renewed the interest in metal complexes for medicinal applications. Researchers have been studying safer and more effective alternatives to cisplatin, including platinum(IV)-based compounds. These compounds have attracted attention because they can be reduced in cells to activate the platinum center and offer advantages such as reducing side effects. This review summarizes the recent achievements in the field of Pt(IV) prodrugs.

INORGANICA CHIMICA ACTA (2023)

Article Chemistry, Inorganic & Nuclear

Disclosing the Preferential Mercury Chelation by SeCys Containing Peptides over Their Cys Analogues

Mikel Bernabeu de Maria, Diego Tesauro, Filippo Prencipe, Michele Saviano, Luigi Messori, Christine Enjalbal, Ryszard Lobinski, Luisa Ronga

Summary: Methylmercury, mercury (II), and mercury (I) chlorides were found to react with vasopressin and its mono- and diselenium analogues to form various mercury-peptide adducts. The replacement of Cys by SeCys in vasopressin increased reactivity towards methylmercury, resulting in the formation of -Se/S-Hg-Se-bridged structures and subsequent demethylation of methylmercury. Competitive experiments showed that CH3HgCl preferred to react with the diselenium analogue rather than vasopressin. The diselenium peptide also demonstrated the ability to displace CH3Hg moieties bound to S in vasopressin. These findings suggest the potential use of selenopeptides for methylmercury chelation and detoxification strategies.

INORGANIC CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Protein Metalation by Medicinal Gold Compounds: Identification of the Main Features of the Metalation Process through ESI MS Experiments

Andrea Geri, Lara Massai, Luigi Messori

Summary: Gold compounds have shown promise as anticancer agents with innovative modes of action, targeting proteins rather than nucleic acids. Through ESI MS measurements, the reactions of various gold compounds with model proteins have been explored, revealing adduct formation and key features of these reactions. This review focuses on five gold compounds and their reactions with four biomolecular targets, showing that cytotoxic gold drugs selectively target cancer cell proteins, particularly cysteine and selenocysteine proteome, leading to severe damage and altered redox state, ultimately causing cancer cell death.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Reactions of Medicinal Gold Compounds with Cathepsin B Explored through Electrospray Mass Spectrometry Measurements

Andrea Geri, Lara Massai, Marko Novinec, Iztok Turel, Luigi Messori

Summary: Medicinal gold compounds exert their pharmacological effects by binding to protein targets. In this study, the reactions between seven representative gold compounds and the cysteine protease cathepsin B were explored, revealing strong interactions with the free cysteine in the enzyme. The findings suggest that the chemical nature of the gold compound plays a significant role in its interaction with proteins.

CHEMPLUSCHEM (2023)

Article Chemistry, Multidisciplinary

An unprecedented palladium-arsenic catalytic cycle for nitriles hydration

Damiano Cirri, Tiziano Marzo, Alessandro Pratesi

Summary: This article describes an unprecedented palladium/arsenic-based catalytic cycle for the hydration of nitriles to amides, which takes place under exceptionally mild conditions of neutral pH and moderate temperature (60°C). The versatility of this new catalytic cycle was tested on various nitriles, ranging from aliphatic to aromatic. The effect of ring substitution with electron withdrawing and electron donating groups, as well as potentially interferent functional groups such as hydroxy or pyridinic nitrogen, was investigated. Furthermore, a pilot study on the potential scalability of this approach for industrial production is presented, demonstrating its potential and rapid scale-up capability.

FRONTIERS IN CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

The effects of two cytotoxic gold(i) carbene compounds on the metabolism of A2780 ovarian cancer cells: mechanistic inferences through NMR analysis

Veronica Ghini, Michele Mannelli, Lara Massai, Andrea Geri, Stefano Zineddu, Tania Gamberi, Luigi Messori, Paola Turano

Summary: NMR metabolomics is a valuable approach for studying changes in cancer cell metabolism caused by anticancer drugs. This study investigates the significant metabolic alterations induced by two cytotoxic gold carbene compounds in A2780 ovarian cancer cells and compares them to auranofin, providing insights into the underlying mechanisms.

RSC ADVANCES (2023)

Article Biochemistry & Molecular Biology

The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes

Beatrice Campanella, Simona Braccini, Giulio Bresciani, Michele De Franco, Valentina Gandin, Federica Chiellini, Alessandro Pratesi, Guido Pampaloni, Lorenzo Biancalana, Fabio Marchetti

Summary: Diiron vinyliminium complexes are promising organometallics with potential anticancer activity. The synthesis and evaluation of [Fe2Cp2(CO)(mu-CO){mu-eta(1):eta(3)-C(R-3)C(R-4)CN(R-1)(R-2)}]CF3SO3 (2a-c, 4a-d) complexes were performed, including their solubility in D2O, Log P-ow, stability in D2O/Me2SO-d(6) mixture, and antiproliferative activity against ovarian cancer cell lines A2780 and A2780cisR, as well as the nontumoral cell line Balb/3T3 clone A31. The cytotoxicity data of 50 vinyliminium complexes were correlated with the structural properties, showing a positive correlation between octanol-water partition coefficient and relative antiproliferative activity on ovarian cancer cell lines. However, the effects of different substituents provided guidelines for the development of novel, more effective compounds. Three additional complexes (4p-r) were designed, synthesized, and biologically investigated, revealing their ability to inhibit thioredoxin reductase enzyme and induce cancer cell production of reactive oxygen species.

METALLOMICS (2023)

暂无数据